Prime models for retinal disease studies.

In the industrialized world, diseases of the retina are the leading causes of blindness. Advances in molecular biology throughout the years have allowed researchers to better observe the close resemblance between animal and human retinal diseases. This paved the way for a better understanding of the pathophysiology of these diseases, facilitating the creation of novel treatment regimens, and efficient gene therapy trials.

Retinal diseases include retinal tear and detachment, diabetic retinopathy, epiretinal membrane, macular hole, retinitis pigmentosa and macular degeneration, most of which are covered by our available models at PharmaLegacy. We also have more models currently under development, and what’s even better, we can customize them to fit your study perfectly.

Contact Us


Ensuring superior quality:

  • Capacity to house over 30,000 rodents and large animals
  • On-site capacity for up to 350 non-human primates, with off-site capacity for up to 30,000 Cynomolgus and Rhesus monkeys
  • Electronically managed, traceable research data
  • 24/7 access to PharmaLegacy representatives

Choose a CRO that has the tenacity to succeed. Choose PharmaLegacy.

Contact Us

Top Pharmaceutical Companies Trust PharmaLegacy For Their Preclinical Ophthalmology Studies

Your preclinical ophthalmology studies call for flawless and affordable ophthalmology models. Download our Ophthalmology brochure and see how our models and decades of expertise can give you the clarity you need in your pipeline.


    We’re ready when you are.

    Tell us your pharmacology challenges.